// App-Quantinova.ai

8553 : Circulating tumor DNA as a non-invasive tool to identify patients at risk for recurrence after chemoradiotherapy in stage III non-small cell lung cancer.

Researchers

Presenter

  • Steven H. Lin

Principal Investigators

  • Xiayu Rao

  • Kimberly C. Banks

  • Ting Xu

  • Jianzhong He

  • Richard Burnham Lanman

  • Amirali Talasaz

  • Jing Wang

  • Zhongxing X. Liao

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • Guardant Health, Rewdwood City, CA

Locations

  • United States

Companies

  • Guardant Health, Inc

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating DNA

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved